Powell Investment Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-12,731
| Closed | -$159K | – | 151 |
|
|
2023
Q3 | $159K | Hold |
12,731
| – | – | 0.1% | 112 |
|
|
2023
Q2 | $172K | Hold |
12,731
| – | – | 0.1% | 105 |
|
|
2023
Q1 | $177K | Hold |
12,731
| – | – | 0.1% | 103 |
|
|
2022
Q4 | $181K | Hold |
12,731
| – | – | 0.11% | 103 |
|
|
2022
Q3 | $174K | Hold |
12,731
| – | – | 0.11% | 103 |
|
|
2022
Q2 | $181K | Hold |
12,731
| – | – | 0.11% | 106 |
|
|
2022
Q1 | $211K | Hold |
12,731
| – | – | 0.12% | 98 |
|
|
2021
Q4 | $245K | Hold |
12,731
| – | – | 0.14% | 91 |
|
|
2021
Q3 | $265K | Hold |
12,731
| – | – | 0.16% | 82 |
|
|
2021
Q2 | $273K | Hold |
12,731
| – | – | 0.17% | 81 |
|
|
2021
Q1 | $251K | Sell |
12,731
-1,000
| -7% | -$19.7K | 0.16% | 84 |
|
|
2020
Q4 | $271K | Sell |
13,731
-1,000
| -7% | -$19.7K | 0.21% | 70 |
|
|
2020
Q3 | $259K | Hold |
14,731
| – | – | 0.22% | 69 |
|
|
2020
Q2 | $265K | Hold |
14,731
| – | – | 0.26% | 68 |
|
|
2020
Q1 | $221K | Hold |
14,731
| – | – | 0.27% | 75 |
|
|
2019
Q4 | $257K | Buy |
+14,731
| New | +$257K | 0.27% | 80 |
|